CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $5.93 billion. The enterprise value is $3.95 billion.
Important Dates
The last earnings date was Thursday, February 12, 2026, after market close.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 95.99 million shares outstanding. The number of shares has increased by 6.60% in one year.
| Current Share Class | 95.99M |
| Shares Outstanding | 95.99M |
| Shares Change (YoY) | +6.60% |
| Shares Change (QoQ) | +4.34% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 78.92% |
| Float | 95.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,629.84 |
| Forward PS | 127.39 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,125.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.32, with a Debt / Equity ratio of 0.11.
| Current Ratio | 13.32 |
| Quick Ratio | 13.25 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.18% and return on invested capital (ROIC) is -312.24%.
| Return on Equity (ROE) | -30.18% |
| Return on Assets (ROA) | -15.76% |
| Return on Invested Capital (ROIC) | -312.24% |
| Return on Capital Employed (ROCE) | -26.86% |
| Weighted Average Cost of Capital (WACC) | 13.41% |
| Revenue Per Employee | $8,931 |
| Profits Per Employee | -$1.48M |
| Employee Count | 393 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.63 million in taxes.
| Income Tax | 3.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.71% in the last 52 weeks. The beta is 1.75, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | +38.71% |
| 50-Day Moving Average | 54.08 |
| 200-Day Moving Average | 54.65 |
| Relative Strength Index (RSI) | 66.27 |
| Average Volume (20 Days) | 1,707,018 |
Short Selling Information
The latest short interest is 21.89 million, so 22.80% of the outstanding shares have been sold short.
| Short Interest | 21.89M |
| Short Previous Month | 21.74M |
| Short % of Shares Out | 22.80% |
| Short % of Float | 22.89% |
| Short Ratio (days to cover) | 12.17 |
Income Statement
In the last 12 months, CRSP had revenue of $3.51 million and -$581.60 million in losses. Loss per share was -$6.47.
| Revenue | 3.51M |
| Gross Profit | -494.78M |
| Operating Income | -568.32M |
| Pretax Income | -577.97M |
| Net Income | -581.60M |
| EBITDA | -548.84M |
| EBIT | -568.32M |
| Loss Per Share | -$6.47 |
Full Income StatementBalance Sheet
The company has $1.98 billion in cash and $206.75 million in debt, with a net cash position of $1.77 billion or $18.43 per share.
| Cash & Cash Equivalents | 1.98B |
| Total Debt | 206.75M |
| Net Cash | 1.77B |
| Net Cash Per Share | $18.43 |
| Equity (Book Value) | 1.92B |
| Book Value Per Share | 20.04 |
| Working Capital | 1.84B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$345.01 million and capital expenditures -$914,000, giving a free cash flow of -$345.93 million.
| Operating Cash Flow | -345.01M |
| Capital Expenditures | -914,000 |
| Free Cash Flow | -345.93M |
| FCF Per Share | -$3.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -16,191.40% |
| Pretax Margin | -16,466.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.60% |
| Shareholder Yield | -6.60% |
| Earnings Yield | -10.17% |
| FCF Yield | -6.05% |
Analyst Forecast
The average price target for CRSP is $70.00, which is 13.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $70.00 |
| Price Target Difference | 13.38% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 351.87% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 6.78 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.78 |
| Piotroski F-Score | 1 |
